<DOC>
	<DOCNO>NCT00613652</DOCNO>
	<brief_summary>The primary purpose study evaluate safety tolerability AZD4877 weekly schedule Japanese patient advance solid malignancy</brief_summary>
	<brief_title>A Phase I , Dose-Escalation Study Assess Safety Drug Levels Blood AZD4877 Japanese Adult Patients</brief_title>
	<detailed_description />
	<criteria>Patients diagnose solid tumour standard treatment respond previous treatment . Patients usually mild symptom capable walk light sedentary work . Patients stay hospital least 4 week . Patients receive treatment anticancer agent within 4 week prior first dose study treatment ; 6 week anticancer agent mitomycin . Patients abnormally low level neutrophil count , platelet count , haemoglobin , indicator bone marrow function . Patients receive therapeutic radiotherapy central nervous system within 3 month prior first dose study treatment ; site within 4 week ; local site within 2 week .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>solid tumor</keyword>
	<keyword>solid malignancy</keyword>
</DOC>